Alzheimer disease and related dementias can increase vulnerability to urinary tract infection (UTI) through age-related, functional, and communication-related factors. This quiz reviews why UTI may be...
A recent meta-analysis demonstrated that adherence to this dietary pattern is associated with an 11–30% reduction in the risk of cognitive impairment, dementia, and Alzheimer disease. This quiz will...
With the approval of the first anti-amyloid antibodies, lecanemab and donanemab, the therapeutic landscape for Alzheimer disease has entered a new era—one that presents both promise and complexity. This...
In an interview with Consultant360, Paul B. Rosenberg, MD, discussed his team’s research on using dronabinol, a legal form of synthetic THC, to treat agitation in patients with Alzheimer disease. What...
In an interview with Consultant360, Kasia Rothenberg, MD, PhD, a geriatric psychiatrist at the Cleveland Clinic Lou Ruvo Center for Brain Health, described the challenges caregivers or family members face...
Agitation in Alzheimer disease isn’t always what it seems. Test your knowledge of the medical, neurologic, and behavioral factors clinicians should consider.
Which neurotransmitter systems are most likely to play a role in agitation symptoms seen in patients with Alzheimer dementia? Take our quiz to test your knowledge!
